This draft Commission Implementing Decision does not renew the approval of bromoacetic acid for use in biocidal products of product-type 4. On 22 December 2023, an application was submitted in accordance with Article 13(1) of Regulation (EU) No 528/2012 for the renewal of the approval of bromoacetic acid for use in biocidal products of product-type 4. On 8 April 2026, the applicant informed the evaluating competent authority that it withdrew their application for the renewal of approval of bromoacetic acid for product-type 4. The draft Decision will therefore propose to not renew the approval of bromoacetic acid for product-type 4. In order to allow sufficient time for economic operators to adapt, treated articles treated with or incorporating bromoacetic acid for use in biocidal products of product-type 4 may be placed on the market for a period of 180 days after the entry into force of this Decision.